FDA Approves, Leqembi, New Treatment for Early Alzheimer’s – The New York Times
Business News
- FDA Approves, Leqembi, New Treatment for Early Alzheimer’s The New York Times
- Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns CNN
- New Alzheimer’s drug offers hope to patients and caregivers | DW News DW News
- FDA approves Alzheimer’s drug that slowed cognitive decline in clinical trial CNBC
- New Alzheimer’s Drug Approved by FDA, Promises to Slow Disease The Wall Street Journal
Source: Business News